CHEK (check-cap.com) רווח נקי למניה (EPS TTM)

Staff optimization and contractor management have determined the current market split for Check-Cap Ltd. (CHEK). The rolling unit profit metric demonstrates efficiency dynamics, where the value of 0.00 reflects this status. The business relies on a unique C-Scan with significant pricing power, utilizing outsourced capsule production and cloud services to scale diagnostics.

Institutional capital assesses the investment attractiveness of Check-Cap Ltd. (CHEK) through the lens of the real yield of each security. This indicator calculates the total annual net profit divided by the number of shares, excluding the impact of issuance changes. By analyzing the company's rolling annual earnings per share, an investor can identify the fundamental monetization trend of cancer screening capsules. Growth in this metric would confirm the efficiency of mass production and high sales margins, while a stable trendline guarantees the reliability of the asset.